Although these medications improve overall glycemic control, the combination of reduced food intake, delayed gastric emptying, and enhanced insulin secretion could theoretically affect glucose availability
Additionally, patients with chronic illnesses, persistent fatigue, or compromised immune function may see improved resilience and reduced recovery times from both everyday stressors and acute illnesses
Regulatory status described here is current as of July 24, 2026 and is actively changing
Compounded semaglutide is not FDA-approved, has not undergone FDA review for safety or effectiveness, and is not the same as, nor equivalent to, Ozempic or Wegovy
According to SingleCare , the average monthly price of Zepbound ranges from $1,280 to $1,500, depending on the pharmacy